In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Johnson & Johnson (NYSE:JNJ) in comparison to its major competitors within the Pharmaceuticals industry. By analyzing crucial financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.
Johnson & Johnson Background
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Johnson & Johnson | 22.18 | 5.13 | 4.39 | 4.69% | $5.68 | $14.87 | 2.34% |
Eli Lilly and Co | 108.24 | 54.52 | 18.48 | 19.02% | $3.12 | $7.09 | 25.98% |
Novo Nordisk A/S | 43.01 | 38.62 | 15.72 | 24.73% | $36.91 | $55.43 | 22.45% |
AstraZeneca PLC | 37.70 | 6.32 | 5.01 | 5.69% | $4.47 | $10.46 | 16.55% |
Novartis AG | 22.11 | 5 | 4.23 | 6.23% | $4.66 | $9.02 | 9.71% |
GSK PLC | 15.94 | 5.11 | 2.32 | 2.64% | $2.07 | $5.39 | 9.16% |
Zoetis Inc | 32.19 | 15.07 | 8.81 | 11.91% | $0.93 | $1.55 | 9.5% |
Takeda Pharmaceutical Co Ltd | 37.03 | 0.97 | 1.58 | 1.53% | $314.89 | $731.71 | 1.33% |
Viatris Inc | 235.60 | 0.69 | 0.92 | -3.7% | $-0.07 | $1.6 | -1.0% |
Dr Reddy's Laboratories Ltd | 20.02 | 3.90 | 3.85 | 5.29% | $22.42 | $42.2 | 6.57% |
Jazz Pharmaceuticals PLC | 22.78 | 1.88 | 1.98 | -0.39% | $0.23 | $0.81 | 1.03% |
Corcept Therapeutics Inc | 23.35 | 4.66 | 5.17 | 6.43% | $0.03 | $0.13 | 31.39% |
Indivior PLC | 448.75 | 242.93 | 2.26 | 940.0% | $0.08 | $0.24 | 12.25% |
Average | 87.23 | 31.64 | 5.86 | 84.95% | $32.48 | $72.14 | 12.08% |